Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

New nuclear medicine test could improve care of patients with type 1 diabetes

Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The new positron emission tomography imaging method could measure beta-cell mass, which would greatly enhance the ability to monitor and guide diabetes therapies.

3 Aug 2018

FDA approves first ever non-surgical treatment for rare neuroendocrine cancers

The U.S. Food and Drug Administration has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma and paraganglioma.

31 Jul 2018

Penn Medicine receives federal government approval to develop imaging guidelines

The United States Congressional Budget Office estimates that 5 percent of the country's gross domestic product is spent on medical tests and procedures that do not improve patient outcomes.

27 Jul 2018

SUSU scientists develop Russian analog of voice prostheses using 3D printing

People who underwent larynx surgery face a necessity of a voice prosthesis implantation, but such artificial windpipes are only produced abroad.

11 Jul 2018

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

A new positron emission tomography imaging method more fully evaluates the extent of rheumatoid arthritis by targeting translocator protein expression in the synovium (joint lining tissue).

10 Jul 2018

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors.

26 Jun 2018

New nuclear medicine approach shows potential for precision treatment of solid tumors

A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children.

26 Jun 2018

Novel theranostic agent designed for precise tumor diagnosis and therapy

A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.

26 Jun 2018

MILabs announces innovative PET imaging features in its new VECTor6 system

The new VECTor6 imaging system is packed with exclusive preclinical PET imaging features including 0.6 mm 18F resolution, the elimination of positron-range blurring for e.g. 124I, simultaneous multi-isotope PET and PET/SPECT tomography, and α- and β-radiotherapy imaging.

26 Jun 2018

New molecular imaging method could help effectively tackle brain conditions

A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

26 Jun 2018

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen, which is commonly expressed on prostate cancer cells.

22 Jun 2018

Interactive preclinical PET-MR workshop demonstrates benefits of multi-modality imaging

An interactive preclinical PET-MR workshop with demonstrations of a new 7T integrated PET-MR multi-modality imaging system from MR Solutions and presentations from participants was held in Dijon last week.

From MR Solutions 21 Jun 2018

New nuclear medicine method appears to effectively detect neuroendocrine tumors

Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods.

7 Jun 2018

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.

4 Jun 2018

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients, according to the findings of a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania.

30 May 2018

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time.

17 May 2018

Novel PET tracer could provide early detection of rheumatoid arthritis

A novel PET tracer developed by Korean researchers can visualize joint inflammation and could provide early diagnosis of rheumatoid arthritis, a common autoimmune disease that causes chronic inflammation of joints and can lead to deformity and dysfunction.

3 May 2018

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine.

2 May 2018

Researchers develop new method to study activity of inflammatory cells

The process that the body sets in motion in the event of inflammation is complex, but also impressive. The main role here is played by immune cells migrating from the blood into the tissue to fight the inflammation.

17 Apr 2018

PET imaging agent may help predict effectiveness of depression treatment

A positron emission tomography imaging agent could show, ahead of time, whether a specific treatment is likely to be effective for major depressive disorder--a debilitating condition that affects more than 14 million Americans.

6 Apr 2018

Nuclear Medicine News and Research

Further Reading

New nuclear medicine test could improve care of patients with type 1 diabetes

FDA approves first ever non-surgical treatment for rare neuroendocrine cancers

Penn Medicine receives federal government approval to develop imaging guidelines

SUSU scientists develop Russian analog of voice prostheses using 3D printing

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

New nuclear medicine approach shows potential for precision treatment of solid tumors

Novel theranostic agent designed for precise tumor diagnosis and therapy

MILabs announces innovative PET imaging features in its new VECTor6 system

New molecular imaging method could help effectively tackle brain conditions

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Interactive preclinical PET-MR workshop demonstrates benefits of multi-modality imaging

New nuclear medicine method appears to effectively detect neuroendocrine tumors

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

Novel PET tracer could provide early detection of rheumatoid arthritis

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

Researchers develop new method to study activity of inflammatory cells

PET imaging agent may help predict effectiveness of depression treatment

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News